ALPHA TRIBE

Vivimed Labs LimitedBoard Meeting, 13-03-2026: Outcome of Board Meeting

13-03-2026 | 11:01 pm

Vivimed Labs' board approved consolidated Q3 FY26 results: Revenue ₹159.89 Cr, Loss ₹16.55 Cr. Auditors issued a qualified report, flagging unprovided loan interest, pending forensic audit impact, and unsupported commission provisions, significantly impacting reported figures. #VIVIMEDLAB

No comments yet. Be the first to comment!

All announcements from Vivimed Labs Limited